Administration of aminoglycosides antibiotics for critically ill patients

Pharmacometrics

Volumn 64, Issue 1-2, 2003, Pages 15-21

  Nishizawa, Kenji ^a   Hirano, Masaaki ^a   Kimura, Akio ^a   Mochizuki, Toru ^a   Yamamoto, Yasuhiro ^a   Yamamura, Shigeo ^b   Momose, Yasunori ^b  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Acute physiology and chronic health evoluation (APACHE) score; Aminoglycosides; Clearance; Distribution volume; Pharmacokinetics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; C REACTIVE PROTEIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COMPARTMENT MODEL; CORRELATION ANALYSIS; CRITICAL ILLNESS; DISEASE SEVERITY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; INFUSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; SCORING SYSTEM;

EID: 0037243463     PISSN: 03008533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bauer L.A., Edwards W.A., Dellinger E.P., Simonowitz D.A. (1983): Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients, Eur. J. Clin. Pharmacol., 24, 643-647.
2. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. (1992): Cytokine serum level during severe sepsis in human IL-6 as a marker of severity, Annals. Surger., 215, 356-362.
3. Dasta J.F., Armstrong D.K. (1988): Variability in aminoglycoside pharmacokinetics in critically ill surgical patients, Crit. Care Med., 16, 327-330.
4. Dofferhoff A.S., de Jong H.J., Bom V.J., van der Meer J., Limburg P.C., de Vries-Hospers H.G., Marrink J., Mulder P.O., Weits J. (1992): Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans, Scand. J. Infect. Dis., 24, 197-204.
5. Etzel J.V., Nafziger A.N., Bertino J.S. (1992): Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia, Antimicrobial Agents and Chemother., 36, 679-681.
6. Firsov A.A., Nasonov V.N. (1991): Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage design, Eur. J. Drug Metab. Pharmacokin., Spec No. 3 327-331.
7. Hickling K.G., Begg E.J., Perry R.E., Atkinson H.C., Sharman J.R., (1991): Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside CL as by creatinine CL in critically ill patients, Crit. Care Med., 19, 1041-1047.
8. Hollingsed T.C., Harper D.J., Jennings J.P., Morris S.E., Saffle J.R., (1993): Aminoglycoside dosing in burn patients using first-dose pharmacokinetics, J. Trauma., 9, 394-398.
9. Kloth D.D., Tegtmeier B.R., Kong C., Akahoshi M.F., Learh S.H., Reatty J.D., (1985): Altered gentamicin pharmacokinetics during the perioperative period, Clin Pharm., 4, 182-185.
10. Knaus W.A., Zimmerman J.E., Wagner D.P., Draper E.A., Lawrence D.E. (1981): APACHE-acute physiology and chronic health evaluation: a physiologically based classification system, Crit. Care Med., 9, 591-597.
11. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. (1985): APACHE II: a severity of disease classification system, Crit. Care. Med., 13, 818-829.
12. Loirat P., Rohan J., Baillet A., Beaufils F., David R., Chapman A. (1978): Increased glomerular filtration rate in patients with majorburns and its effect on the pharmacokinetics of tobramycin, New Engl. J. Med., 299, 915-919
13. Marik P.E. (1993): Aminoglycoside volume of distribution and illness severity in criti cally ill septic patients, Anestesia Int Care., 21, 172-173.
14. Marik P.E., Havlik I., Monteagudo T. S. E., Lipman J. (1991): The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens, J. Antimicrobial. Chemother, 27, Suppl.C,81-89.
15. Moore R.D., Smith C.R., Lietman P.S. (1984): Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, Am. J. Med., 77, 657-662.
16. Rosario M.C., Thomson A.H., Jodrell D.I., Sharp C.A., Elliott H.L. (1998): Population phamacokinetics of getamicin in patients with cancer, Br. J. Clin. Pharmacol., 46, 229-236.
17. Triginer C., lzquierdo I., Fernandez R., Rello J., Torrent J., Benito S., Net A. (1990): Gentamicin volume of distribution in critically ill septic patients, Intensive Care Med., 16, 303-306.
18. Zaske D.E., Sawchuk R.J., Gerding D.N., Strate R.G. (1987): Increased dosage requirements of gentamicin in burn patients, J. Trauma., 16, 824-828.